Previous 10 | Next 10 |
home / stock / amgn / amgn articles
Viking Therapeutics (NASDAQ: VKTX), a clinical-stage company focused on developing novel therapeutics for metabolic and endocrine disorders, has be...
Trading in U.S. index futures suggests stocks may be off to a lackluster start again on Thursday. Much of the negativity in the recent session was ...
U.S. stocks were higher, with the Nasdaq Composite gaining over 100 points on Monday. Shares of Spirit Airlines, Inc. (NYSE:SAVE) fell sharply duri...
Amgen Inc (NASDAQ:AMGN) reported first-quarter (Q1) earnings Thursday, touting adjusted EPS of $3.96, which beat the analyst consensus estimate o...
U.S. stocks were higher, with the Dow Jones index gaining over 400 points on Friday. Shares of Amgen Inc. (NASDAQ:AMGN) rose sharply during Friday&...
Stocks look set to carry forward the upward momentum on Friday amid some earnings cheer, although a tinge of nervousness is evident ahead of the al...
Shares of Apple Inc. (NASDAQ:AAPL) rose sharply in today's pre-market trading after the company reported better reported better-than-expected ...
Amgen, Inc. (NASDAQ:AMGN) shares rallied over 14% in Thursday’s after-hours trading after the biopharma reported a double beat and offered an...
Thursday saw major U.S. indices closing on a positive note, with the Dow Jones Industrial Average climbing 0.85% to reach 38,225.66, while the S&am...
News, Short Squeeze, Breakout and More Instantly...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...
2024-07-12 12:30:05 ET UBS analyst issues NEUTRAL recommendation for AMGN on July 12, 2024 10:22AM ET. The previous analyst recommendation was Neutral. AMGN was trading at $331.355 at issue of the analyst recommendation. The overall analyst consensus : BUY. Current a...